Meta-Analysis of Comparison of Effectiveness of Lowering Apolipoprotein B Versus Low-Density Lipoprotein Cholesterol and Nonhigh-Density Lipoprotein Cholesterol for Cardiovascular Risk Reduction in Randomized Trials

2012/08/17 by Jennifer G. Robinson, Songfeng Wang, Terry A. Jacobson · 1 citation
Biochemistry, Genetics and Molecular Biology · Medicine · #Cancer, Lipids, and Metabolism #Diabetes, Cardiovascular Risks, and Lipoproteins #Lipoproteins and Cardiovascular Health

paper · doi:10.1016/j.amjcard.2012.07.007

openalex publication_date 2012/08/17 · crossref created 2012/08/17 · crossref issued 2012/11/01 · crossref published 2012/11/01 · crossref published-print 2012/11/01 · openalex created_date 2025/10/10 · crossref deposited 2025/11/02 · crossref indexed 2026/06/03 · openalex updated_date 2026/07/29

Citations

• Study of Heart and Renal Protection (SHARP): Randomized trial to assess the effects of lowering low-density lipoprotein cholesterol among 9,438 patients with chronic kidney disease
• Bayes Factors

Cited by

• Cholesterol [wikipedia]